| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 2342 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 2342 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2342 |
| 3 | AZACITIDINE | 2227 |
| 4 | VENETOCLAX | 1935 |
| 5 | ETOPOSIDE | 1473 |
| 6 | CYTARABINE | 1332 |
| 7 | DOXORUBICIN | 1324 |
| 8 | AZACITIDINE FOR | 1318 |
| 9 | LENALIDOMIDE | 1305 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 313 | 0.1288 |
| 1 | GILTERITINIB | 342 | 0.0838 |
| 2 | AZACITIDINE | 2227 | 0.0739 |
| 3 | DECITABINE | 242 | 0.0554 |
| 4 | MITOXANTRONE HYDROCHLORIDE | 300 | 0.0477 |
| 5 | GEMTUZUMAB OZOGAMICIN | 151 | 0.0412 |
| 6 | CARMUSTINE | 172 | 0.0365 |
| 7 | ENASIDENIB MESYLATE | 119 | 0.0353 |
| 8 | CHLORAMBUCIL | 131 | 0.0333 |
| 9 | VENETOCLAX | 1935 | 0.0308 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 4251 |
| 1 | Alkylating Drug [EPC] | 2921 |
| 2 | Corticosteroid [EPC] | 2346 |
| 3 | BCL-2 Inhibitor [EPC] | 1935 |
| 4 | Platinum-based Drug [EPC] | 1644 |
| 5 | Topoisomerase Inhibitor [EPC] | 1505 |
| 6 | Thalidomide Analog [EPC] | 1328 |
| 7 | Azole Antifungal [EPC] | 1111 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1035 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 976 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 313 | 0.1288 |
| 1 | CD33-directed Immunoconjugate [EPC] | 151 | 0.0412 |
| 2 | Actinomycin [EPC] | 71 | 0.0321 |
| 3 | BCL-2 Inhibitor [EPC] | 1935 | 0.0308 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 129 | 0.0220 |
| 5 | Topoisomerase Inhibitor [EPC] | 1505 | 0.0196 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 355 | 0.0166 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 4251 | 0.0155 |
| 8 | Hematopoietic Stem Cell Mobilizer [EPC] | 21 | 0.0141 |
| 9 | Histone Deacetylase Inhibitor [EPC] | 48 | 0.0124 |